Developer docs
API playgroundTry for free, no card

Search company profiles

Poly-Med

Full company profile

uuid000auez

Namestring
Poly-Med
Legal namestring
Poly-Med Incorporated
Websiteurl
poly-med.com
Company typeenum
Private
Founded yearint
1993
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAnderson, United States
HQ citystring
Anderson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioresorbable polymers, absorbable medical devices, contract manufacturing, medical textiles, electrospinning services
Industry4 codes
PRIMARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYIMAAADAG
Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYIMAAABAA
Polymer Filaments (FDM/FFF)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Materials (Polymers, Metals, Ceramics, Composites)
SECONDARYIMANAFAC
Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom)
NAICS code3 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
  • Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing3252
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Miscellaneous Plastics Products3080
Product category
Medical Device Contract Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Contract Development & Manufacturing (CDMO Services)
TypeProfessional Services
Description

Full-service CDMO providing design, development, and manufacturing of custom absorbable medical devices. Services include design verification, analytical testing, and quality management. Revenue generated through project-based contracts and manufacturing agreements with medical device companies.

poly-med.com
2Bioresorbable Polymer Sales
TypeHardware Sales
Description

Sale of raw absorbable polymers including Max-Prene®, Dioxaprene®, Lactoprene®, Glycoprene®, Aquaprene®, Strataprene®, and Caproprene® product families. Polymers sold for conversion via injection molding, extrusion, electrospinning, and 3D printing.

poly-med.com
33D Printing Materials
TypeHardware Sales
Description

Sale of medical-grade 3D printing filaments (Lactoprene® 100M, Dioxaprene® 100M, Max-Prene® 955, etc.) and Photoset® resins for additive manufacturing of medical devices.

poly-med.com
4Analytical Testing Services
TypeProfessional Services
Description

In-house analytical capabilities including inherent viscosity measurements, differential scanning calorimetry, gas chromatography, gel permeation chromatography, in-vitro degradation studies, and custom test method development.

poly-med.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Pricing details1 tier
1Custom CDMO services with quote-based pricing tailored to specific project requirements
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is project-specific based on device complexity, volume requirements, regulatory pathway, and service scope. No public pricing tiers available.

poly-med.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Poly-Med is a vertically integrated Contract Development & Manufacturing Organization (CDMO) that designs, develops, and manufactures custom absorbable medical implants and bioresorbable polymers for medical device and pharmaceutical companies. Its offerings span proprietary branded polymer families (Max-Prene®, Dioxaprene®, Lactoprene®, Glycoprene®, etc.), bioresorbable extrusions (monofilament fibers, multifilament yarns, films), biomedical textiles, medical-grade electrospinning for nanofibrous scaffolds, and 3D printing (filament-based FFF and resin-based SLA/DLP) — supported by design, development, analytical testing, and ISO 13485 certified manufacturing services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Absorbable implants that resorb within the body without a trace, minimizing the need for follow-up surgical procedures
+2 more records
Product overview1 text field

Poly-Med is a Contract Development & Manufacturing Organization (CDMO) specializing in bioresorbable/ absorbable medical devices. Their vertically integrated platform spans from polymer synthesis to finished medical device manufacturing. Core offerings include: bioresorbable polymers (Max-Prene®, Dioxaprene®, Lactoprene®, Strataprene®, Caproprene®, Glycoprene® families), bioresorbable extrusions (monofilament fibers, multifilament yarns, films), biomedical textiles (knitted and braided constructs), electrospinning services for nanofibrous scaffolds, and 3D printing (both filament-based FFF and resin-based SLA/DLP). Services include design & development, vertically integrated manufacturing, and analytical testing. The company holds ISO 13485 certification and operates cGMP-compliant facilities.

Product and service9 records
1Bioresorbable Polymers
CategoryBioresorbable Polymers
Description

Medical-grade absorbable polymers including Max-Prene®, Dioxaprene®, Lactoprene®, Strataprene®, Caproprene™, Glycoprene®, and Aquaprene® polymer families for use in implantable medical devices. These polymers transform the healing process by temporarily restoring functionality in targeted areas and resorb within the body without a trace, minimizing the need for follow-up surgical procedures.

2Bioresorbable Extrusions
CategoryBioresorbable Extrusions
Description

Polymers extruded into monofilament fibers, multifilament yarns, or films as inputs into biomedical textile applications, allowing customers to select the filament for their design rather than designing for an existing filament.

3Biomedical Textiles
CategoryBiomedical Textiles
Description

Custom medical-grade textiles including warp knit, weft knit, and braided constructs for implantable medical devices, with polymers selected to enable more responsive designs and better patient outcomes.

4Electrospinning
CategoryElectrospinning Services
Description

Medical-grade electrospinning services producing nanofibrous scaffolds for tissue engineering and regenerative medicine applications, using electrostatic fiber fabrication to draw charged polymer solutions into submicron-scale fiber diameters that mimic native tissue properties.

53D Printing
CategoryAdditive Manufacturing Services
Description

Additive manufacturing services using filament-based (FFF) and resin-based (SLA/DLP) approaches to create lattice-based architectures with bioresorbable implants inaccessible via injection molding.

6Photoset® Resin
CategoryBioresorbable Resins
Description

First-in-class bioresorbable fast-degrading resins for photopolymerization 3D printing methods including SLA, DLP, and two-photon polymerization, utilizing monomeric constituents used in medical devices for over 40 years.

7Max-Prene® 955
CategoryBioresorbable Polymer Sub-product
Description

Custom 95/5 poly(glycolide-co-lactide) copolymer with high tensile modulus and faster degradation profile; exhibits strength loss in 1-4 weeks with complete mass loss in approximately 6 months.

8Dioxaprene® 100M
CategoryBioresorbable Polymer Sub-product
Description

100% polydioxanone (PDO) linear homopolymer with lower initial modulus, extended strength retention, and increased flexibility; maintains strength for 4-6 weeks with complete mass loss in approximately 9 months.

9Lactoprene® 100M
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1The SiMT (Southeastern Institute of Manufacturing & Technology)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2017-08-04
Description

Partnership with The SiMT in Florence, SC for additive manufacturing experimentation. Poly-Med 3D printing team toured facilities including advanced machining center, listening center, and additive manufacturing center. Potential for SiMT to experiment with Poly-Mel's materials.

poly-med.com
2Resorbable Devices AB
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Swedish company developing the LigaTie® resorbable ligation device using Poly-Mel's Glycoprene® polymers. The device addresses challenges in surgical ligation procedures, restricting blood flow and preventing blood loss and air leaks. Poly-Med supports material development of novel flexible, fast-degrading absorbable polymer meeting the device's demanding specifications. Successful veterinary applications include canine neutering, lung lobectomy, and tissue sealing procedures.

poly-med.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with QUT (Mina Mohseni, Professor Dietmar Hutmacher, Dr. Nathan Castro) to promote research on Poly-Mel's unique bioresorbable medical grade 3D printing filaments. Research characterized material properties and evaluated potential use in both hard and soft tissue engineering applications. Publication in MDPI journal evaluated Lactoprene® 100M, Max-Prene® 955, Dioxaprene® 100M, and Caproprene™ 100M filaments in fused filament fabrication tissue scaffolding.

4SCBIO
Strategic tierCoreTypeStrategic or Co-development Partner
Description

South Carolina's life sciences industry association. Poly-Med represented on SCBIO Board of Directors. SCBIO describes Poly-Mel's platform technology, innovation, and dynamic research as resulting in leading edge products benefiting top medical device and pharmaceutical companies.

poly-med.com
5MADE in South Carolina
Strategic tierMinorTypeStrategic or Co-development Partner
Description

$20 million NSF EPSCoR-funded initiative (Materials Assembly and Design Excellence) involving 10 universities across South Carolina. Poly-Med listed as a corporate partner among AVX, BMW, Boeing, GE, IBM, Michelin, and Milliken. Program aims to discover sustainable approaches for design and assembly of advanced materials serving STEM research, education, and workforce needs.

poly-med.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Active participation in ASTM Committee F04 (Medical and Surgical Materials and Devices) and F42 (Additive Manufacturing). Poly-Mel's CTO Dr. Scott Taylor organized and chaired ASTM workshop on use of absorbable polymers for medical devices. Company working in F04.11 group to develop new standard for Polydioxanone resin.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-organized ASTM Workshop on Characterization of Fiber-based Scaffolds and Devices hosted by ARMI in Manchester, NH. Workshop featured seminar discussions from academia, clinicians, and industrial spotlights on emerging technologies and application of fiber-based scaffolds.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large medical device OEM and contract manufacturer with absorbable suture and bioresorbable product lines. Competes with Poly-Med both as a buyer of absorbable polymers (in some cases) and as an integrated developer of absorbable implants in overlapping indications.

TypeBroad incumbent
Description

Dutch ingredients company producing PURAC® lactide and glycolide monomers used as the building blocks for bioresorbable polymers. Operates upstream of Poly-Med in the absorbable value chain but increasingly downstream through partnerships and is a key competitive force in medical-grade lactide supply.

TypeBroad incumbent
Description

Global specialty chemicals company with pharmaceutical and medical polymer offerings used in controlled-release and implantable applications. A broader incumbent competing for medical-grade polymer and CDMO-adjacent business.

TypeEmerging player
Description

Developer of biodegradable polymers for drug-eluting fibers, textile scaffolds, and implantable devices. Smaller and more research-oriented, but a credible emerging peer in the absorbable polymer and medical textile space where Poly-Med competes.

TypeDirect peer
Description

Global specialty chemicals company selling the Resomer® line of bioresorbable polymers (PLA, PLGA, PCL, PDO) for medical devices and parenteral drug delivery. Most direct competitor to Poly-Med's branded polymer families and a benchmark for scale in absorbable polymer supply.

6Zeus Industrial Products
TypeDirect peer
Description

Specialty manufacturer of polymer extrusions, tubing, and fiber components for medical devices including absorbable and biomaterial applications. Directly comparable to Poly-Med's bioresorbable extrusion and biomedical textile capabilities.

TypeDirect peer
Description

Specialty compounder and supplier of medical-grade polymer materials including bioresorbable and radiopaque compounds for implantable devices. Competes with Poly-Med on custom polymer supply for downstream medical device manufacturers.

TypeDirect peer
Description

US-based biomedical textile and implantable component manufacturer producing woven, knit, and braided structures including bioresorbable scaffolds. Directly competes with Poly-Med's biomedical textile and electrospinning offerings for regenerative and tissue engineering customers.

9Bezwada Biomedical
TypeEmerging player
Description

R&D-focused supplier of functional absorbable polymers and custom synthesis for medical device applications. Comparable to Poly-Med's custom polymer synthesis business and a direct peer in specialty absorbable chemistry development.

TypeBroad incumbent
Description

Major biomedical materials business with a deep portfolio in bioresorbable polymers, UHMWPE, and coatings used in orthopedic, cardiovascular, and general surgery devices. Competes with Poly-Med on absorbable polymers and broader CDMO-adjacent material supply.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Poly-Med

Medical Device Contract Manufacturingpoly-med.com

Poly-Med firmographics

Firmographics
Name
Poly-Med
Legal name
Poly-Med Incorporated
Website
https://poly-med.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Poly-Med industry classification

Industry
Product category
Medical Device Contract Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Miscellaneous Plastics Products (3080)
akta.pro industry
PRIMARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYIMAAADAG
Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYIMAAABAA
Polymer Filaments (FDM/FFF)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Materials (Polymers, Metals, Ceramics, Composites)
SECONDARYIMANAFAC
Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom)

Keywords

  • Bioresorbable polymers
  • Absorbable medical devices
  • Contract manufacturing
  • Medical textiles
  • Electrospinning services

Where Poly-Med is headquartered

Location

Headquarters

HQ city
Anderson
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Poly-Med business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Contract Development & Manufacturing (CDMO Services): Full-service CDMO providing design, development, and manufacturing of custom absorbable medical devices. Services include design verification, analytical testing, and quality management. Revenue generated through project-based contracts and manufacturing agreements with medical device companies.
  2. Bioresorbable Polymer Sales: Sale of raw absorbable polymers including Max-Prene®, Dioxaprene®, Lactoprene®, Glycoprene®, Aquaprene®, Strataprene®, and Caproprene® product families. Polymers sold for conversion via injection molding, extrusion, electrospinning, and 3D printing.
  3. 3D Printing Materials: Sale of medical-grade 3D printing filaments (Lactoprene® 100M, Dioxaprene® 100M, Max-Prene® 955, etc.) and Photoset® resins for additive manufacturing of medical devices.
  4. Analytical Testing Services: In-house analytical capabilities including inherent viscosity measurements, differential scanning calorimetry, gas chromatography, gel permeation chromatography, in-vitro degradation studies, and custom test method development.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom CDMO services with quote-based pricing tailored to specific project requirements

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Poly-Med product offering

Product offering

Core offering

Poly-Med is a vertically integrated Contract Development & Manufacturing Organization (CDMO) that designs, develops, and manufactures custom absorbable medical implants and bioresorbable polymers for medical device and pharmaceutical companies. Its offerings span proprietary branded polymer families (Max-Prene®, Dioxaprene®, Lactoprene®, Glycoprene®, etc.), bioresorbable extrusions (monofilament fibers, multifilament yarns, films), biomedical textiles, medical-grade electrospinning for nanofibrous scaffolds, and 3D printing (filament-based FFF and resin-based SLA/DLP) — supported by design, development, analytical testing, and ISO 13485 certified manufacturing services.

Product overview

Poly-Med is a Contract Development & Manufacturing Organization (CDMO) specializing in bioresorbable/ absorbable medical devices. Their vertically integrated platform spans from polymer synthesis to finished medical device manufacturing. Core offerings include: bioresorbable polymers (Max-Prene®, Dioxaprene®, Lactoprene®, Strataprene®, Caproprene®, Glycoprene® families), bioresorbable extrusions (monofilament fibers, multifilament yarns, films), biomedical textiles (knitted and braided constructs), electrospinning services for nanofibrous scaffolds, and 3D printing (both filament-based FFF and resin-based SLA/DLP). Services include design & development, vertically integrated manufacturing, and analytical testing. The company holds ISO 13485 certification and operates cGMP-compliant facilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bioresorbable Polymers Medical-grade absorbable polymers including Max-Prene®, Dioxaprene®, Lactoprene®, Strataprene®, Caproprene™, Glycoprene®, and Aquaprene® polymer families for use in implantable medical devices. These polymers transform the healing process by temporarily restoring functionality in targeted areas and resorb within the body without a trace, minimizing the need for follow-up surgical procedures.
  • Bioresorbable Extrusions Polymers extruded into monofilament fibers, multifilament yarns, or films as inputs into biomedical textile applications, allowing customers to select the filament for their design rather than designing for an existing filament.
  • Biomedical Textiles Custom medical-grade textiles including warp knit, weft knit, and braided constructs for implantable medical devices, with polymers selected to enable more responsive designs and better patient outcomes.
  • Electrospinning Medical-grade electrospinning services producing nanofibrous scaffolds for tissue engineering and regenerative medicine applications, using electrostatic fiber fabrication to draw charged polymer solutions into submicron-scale fiber diameters that mimic native tissue properties.
  • 3D Printing Additive manufacturing services using filament-based (FFF) and resin-based (SLA/DLP) approaches to create lattice-based architectures with bioresorbable implants inaccessible via injection molding.
  • Photoset® Resin First-in-class bioresorbable fast-degrading resins for photopolymerization 3D printing methods including SLA, DLP, and two-photon polymerization, utilizing monomeric constituents used in medical devices for over 40 years.
  • Max-Prene® 955 Custom 95/5 poly(glycolide-co-lactide) copolymer with high tensile modulus and faster degradation profile; exhibits strength loss in 1-4 weeks with complete mass loss in approximately 6 months.
  • Dioxaprene® 100M 100% polydioxanone (PDO) linear homopolymer with lower initial modulus, extended strength retention, and increased flexibility; maintains strength for 4-6 weeks with complete mass loss in approximately 9 months.
  • Lactoprene® 100M

Quantifiable outcome

  • Absorbable implants that resorb within the body without a trace, minimizing the need for follow-up surgical procedures
  • +2 more outcomes

Companies that use Poly-Med

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Poly-Med technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Poly-Med partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor and core.

  • The SiMT (Southeastern Institute of Manufacturing & Technology)minorStrategic or Co-development Partner · 4 August 2017Partnership with The SiMT in Florence, SC for additive manufacturing experimentation. Poly-Med 3D printing team toured facilities including advanced machining center, listening center, and additive manufacturing center. Potential for SiMT to experiment with Poly-Mel's materials.
  • Resorbable Devices ABcoreStrategic or Co-development PartnerSwedish company developing the LigaTie® resorbable ligation device using Poly-Mel's Glycoprene® polymers. The device addresses challenges in surgical ligation procedures, restricting blood flow and preventing blood loss and air leaks. Poly-Med supports material development of novel flexible, fast-degrading absorbable polymer meeting the device's demanding specifications. Successful veterinary applications include canine neutering, lung lobectomy, and tissue sealing procedures.
  • Queensland University of TechnologycoreStrategic or Co-development PartnerResearch collaboration with QUT (Mina Mohseni, Professor Dietmar Hutmacher, Dr. Nathan Castro) to promote research on Poly-Mel's unique bioresorbable medical grade 3D printing filaments. Research characterized material properties and evaluated potential use in both hard and soft tissue engineering applications. Publication in MDPI journal evaluated Lactoprene® 100M, Max-Prene® 955, Dioxaprene® 100M, and Caproprene™ 100M filaments in fused filament fabrication tissue scaffolding.
  • SCBIOcoreStrategic or Co-development PartnerSouth Carolina's life sciences industry association. Poly-Med represented on SCBIO Board of Directors. SCBIO describes Poly-Mel's platform technology, innovation, and dynamic research as resulting in leading edge products benefiting top medical device and pharmaceutical companies.
  • MADE in South CarolinaminorStrategic or Co-development Partner$20 million NSF EPSCoR-funded initiative (Materials Assembly and Design Excellence) involving 10 universities across South Carolina. Poly-Med listed as a corporate partner among AVX, BMW, Boeing, GE, IBM, Michelin, and Milliken. Program aims to discover sustainable approaches for design and assembly of advanced materials serving STEM research, education, and workforce needs.
  • ASTM InternationalcoreStrategic or Co-development PartnerActive participation in ASTM Committee F04 (Medical and Surgical Materials and Devices) and F42 (Additive Manufacturing). Poly-Mel's CTO Dr. Scott Taylor organized and chaired ASTM workshop on use of absorbable polymers for medical devices. Company working in F04.11 group to develop new standard for Polydioxanone resin.
  • Advanced Regenerative Manufacturing Institute (ARMI)minorStrategic or Co-development PartnerCo-organized ASTM Workshop on Characterization of Fiber-based Scaffolds and Devices hosted by ARMI in Manchester, NH. Workshop featured seminar discussions from academia, clinicians, and industrial spotlights on emerging technologies and application of fiber-based scaffolds.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Poly-Med competitors and assessment

Company assessment

Broad incumbents

  • Teleflex Medical OEM: Large medical device OEM and contract manufacturer with absorbable suture and bioresorbable product lines. Competes with Poly-Med both as a buyer of absorbable polymers (in some cases) and as an integrated developer of absorbable implants in overlapping indications.
  • Corbion: Dutch ingredients company producing PURAC® lactide and glycolide monomers used as the building blocks for bioresorbable polymers. Operates upstream of Poly-Med in the absorbable value chain but increasingly downstream through partnerships and is a key competitive force in medical-grade lactide supply.
  • Ashland: Global specialty chemicals company with pharmaceutical and medical polymer offerings used in controlled-release and implantable applications. A broader incumbent competing for medical-grade polymer and CDMO-adjacent business.
  • DSM Biomedical (now part of dsm-firmenich / Danaher legacy): Major biomedical materials business with a deep portfolio in bioresorbable polymers, UHMWPE, and coatings used in orthopedic, cardiovascular, and general surgery devices. Competes with Poly-Med on absorbable polymers and broader CDMO-adjacent material supply.

Emerging players

  • TissueGen: Developer of biodegradable polymers for drug-eluting fibers, textile scaffolds, and implantable devices. Smaller and more research-oriented, but a credible emerging peer in the absorbable polymer and medical textile space where Poly-Med competes.
  • Bezwada Biomedical: R&D-focused supplier of functional absorbable polymers and custom synthesis for medical device applications. Comparable to Poly-Med's custom polymer synthesis business and a direct peer in specialty absorbable chemistry development.

Direct peers

  • Evonik: Global specialty chemicals company selling the Resomer® line of bioresorbable polymers (PLA, PLGA, PCL, PDO) for medical devices and parenteral drug delivery. Most direct competitor to Poly-Med's branded polymer families and a benchmark for scale in absorbable polymer supply.
  • Zeus Industrial Products: Specialty manufacturer of polymer extrusions, tubing, and fiber components for medical devices including absorbable and biomaterial applications. Directly comparable to Poly-Med's bioresorbable extrusion and biomedical textile capabilities.
  • Foster Corporation: Specialty compounder and supplier of medical-grade polymer materials including bioresorbable and radiopaque compounds for implantable devices. Competes with Poly-Med on custom polymer supply for downstream medical device manufacturers.
  • Secant Group: US-based biomedical textile and implantable component manufacturer producing woven, knit, and braided structures including bioresorbable scaffolds. Directly competes with Poly-Med's biomedical textile and electrospinning offerings for regenerative and tissue engineering customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Poly-Med social profiles

Digital presence

Poly-Med compliance and trust

Trust signal

Compliance2 records

Poly-Med financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Poly-Med leadership team

Management profile

Number of profiles

Profiles5 records

Poly-Med funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Poly-Med M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Poly-Med

What does Poly-Med do?

Poly-Med is a vertically integrated Contract Development & Manufacturing Organization (CDMO) that designs, develops, and manufactures custom absorbable medical implants and bioresorbable polymers for medical device and pharmaceutical companies. Its offerings span proprietary branded polymer families (Max-Prene®, Dioxaprene®, Lactoprene®, Glycoprene®, etc.), bioresorbable extrusions (monofilament fibers, multifilament yarns, films), biomedical textiles, medical-grade electrospinning for nanofibrous scaffolds, and 3D printing (filament-based FFF and resin-based SLA/DLP) — supported by design, development, analytical testing, and ISO 13485 certified manufacturing services.

Is Poly-Med a public or private company?

Poly-Med is a private company. It is classified as family owned and is currently operating.

When was Poly-Med founded?

Poly-Med was founded in 1993. It employs 101 to 250 people.

Where is Poly-Med based?

Poly-Med is headquartered in Anderson, United States, in the North America region.

How does Poly-Med make money?

Four revenue lines are on record. Contract Development & Manufacturing (CDMO Services) is the primary driver. The others are bioresorbable Polymer Sales, 3D Printing Materials and analytical Testing Services.

Who are Poly-Med's main competitors?

Broad incumbents on record are Teleflex Medical OEM, Corbion, Ashland and DSM Biomedical (now part of dsm-firmenich / Danaher legacy). Emerging players are TissueGen and Bezwada Biomedical. Direct peers are Evonik, Zeus Industrial Products, Foster Corporation and Secant Group.

Does Poly-Med have an API?

No public API is recorded for Poly-Med.

What industry is Poly-Med in?

Poly-Med's product category is Medical Device Contract Manufacturing. Its primary akta.pro industry code is HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO, with a secondary code of IMAAADAG, Medical & Dental 3D Printing Services (patient-specific devices, dental labs). Its NAICS code is 3391 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales